FinBERT, a financial-language model, scores this headline as positive (95% confidence). That is the news tone only — not the full stock rating.
Stocks › GRFS
Grifols Sa (GRFS) stock analysis
WEAK BUY 20% confidence · analysed Nov 2, 2026
On Nov 2, 2026, our model rated Grifols Sa (GRFS) WEAK BUY with 20% confidence at a price of $8.52. That means the signals lean positive, but they are mixed, so conviction is low.
Analysed price$8.52
Technical picture
The 14-day RSI is 86, above 70, which is overbought: buyers have been very aggressive and a pause or pullback is common from here.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.
Volume is 1.9x its 20-day average, so the latest move has real participation behind it.
Trend structure and money flow
Market structure shows a bullish change of character (CHoCH): the first break against the prevailing trend, an early hint of a possible reversal.
The most recent swing high is $8.38 and the swing low is $6.87; traders often treat these as resistance and support.
Fundamentals
The PEG ratio is 0.19, which looks cheap relative to its expected growth.
The company reports a profit margin of 6.1% and revenue growth of -0.9%.
In its latest quarter it earned $0.17 per share, which missed the $0.28 analysts expected, with revenue +4.9% year over year.
Wall Street's average rating is 2.0 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $10.37.
The next earnings report is expected around Feb 25, 2027; prices often move sharply around earnings.
Trade plan from the model
The model's long / bullish plan uses an entry near $8.52, a target of $8.88 (+4.2%) and a stop-loss at $8.02 (-5.9%).
That is a reward-to-risk ratio of about 0.7 to 1: the potential loss is bigger than the gain, a weak setup.
The plan has a time limit: reassess by Nov 12, 2026 whatever the price does.
Entry$8.52
Target$8.88
Stop-loss$8.02
Reassess byNov 12, 2026
The model's one-paragraph read
Leans BUY — composite score +0.20 (WEAK BUY). Technicals: RSI 85.68, MACD bullish, price above SMA50. Fundamentals: PEG 0.19, margin 6.1%, revenue growth -0.9%. Financial results: YoY revenue +4.9%, last EPS surprise -39.3%, next earnings 2027-02-25. Smart Money Concepts: CHoCH bullish (possible trend reversal up). FinGPT news read: positive. Suggested levels: entry $8.52, target $8.88, stop-loss $8.02, exit by 2026-11-12 (10-calendar-day max hold (time-stop; reassess by this date regardless of P&L)).
Past ratings for GRFS
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Nov 2, 2026 | WEAK BUY | 20% | $8.52 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on GRFS
Nov 2, 2026 · Grifols stock up: Q3 revenue tops estimates as immunoglobulin sales drive growth
- Nov 2, 2026: Grifols stock up: Q3 revenue tops estimates as immunoglobulin sales drive growth (Investing.com)
Frequently asked questions
Is GRFS a buy right now?
As of Nov 2, 2026, our automated model rates Grifols Sa (GRFS) WEAK BUY with 20% confidence: the signals lean positive, but they are mixed, so conviction is low. This is a model output for education, not personal investment advice.
What is the price target for GRFS?
The model's most recent plan targets $8.88 with a stop-loss at $8.02, from an entry near $8.52.
When does Grifols Sa report earnings next?
The next earnings report is expected around Feb 25, 2027.
What does a WEAK BUY rating mean?
A WEAK BUY rating means the signals lean positive, but they are mixed, so conviction is low.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.